High Short Interest in RLAY
Relay Therapeutics, Inc. (RLAY) is currently under significant pressure from short sellers, with short interest reaching 20.3% of its float. This high level of short interest, combined with a days-to-cover ratio of 14.2, suggests that a substantial portion of the market is betting against the company's near-term performance. The borrow fee remains relatively low at 0.4%, suggesting that despite the high short interest, shares remain readily available for lending.
Fundamental Context
Relay Therapeutics has seen its shares outstanding increase by 65% over the past two years, which may be a factor in the current short sentiment. With a cash runway of approximately 3.9 months, the company's financial position is a critical focal point for both bulls and bears. The combination of high short interest and a limited cash runway creates a volatile setup for the stock.
Key Takeaways
- Short interest is 20.3% of the float.
- Days-to-cover ratio is 14.2, indicating a high level of short positioning.
- Borrow fee is currently 0.4%.
- Shares outstanding have grown by 65% in the last two years.
The Bottom Line
With over 20% of its float shorted, RLAY is a high-conviction short play. Investors should monitor the company's cash runway and any potential catalysts that could trigger a squeeze.
Signal data sourced from CurvedTrading. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.